Monday, May 13, 2024
12:00PM – 1:00PM ET
Please note this TeleECHO program is 12:00PM Eastern, 11:00AM Central, 10:00AM Mountain and 9:00AM Pacific.
PRESENTING FACULTY
 |
Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS Associate Professor of Medicine and Pediatrics Obesity Medicine Physician-Scientist Massachusetts General Hospital Harvard Medical School Boston, MA |
PROGRAM OVERVIEW
This educational program aims to increase the use of recommended diagnostic and treatment strategies for obesity in the specialist and primary care settings and engage patients in shared decision making when devising weight reduction strategies, ultimately improving the health outcomes of patients with obesity.
TARGET AUDIENCE
This educational activity is intended for obesity specialists, endocrinologists, primary care physicians, and nurses on a global level, particularly in Germany, Italy, Spain, France, China, Japan, Brazil, UAE, and Saudi Arabia.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Explain the biological mechanisms that defend body weight and encourage weight regain following diet-induced weight loss
- Provide evidence-based diagnosis and treatment for patients with obesity based on up-to-date guidelines and clinical data
- Compare the safety and efficacy of established and emerging antiobesity medications
- Engage patients in shared decision making when selecting weight reduction strategies
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
EACCME CREDIT DESIGNATION STATEMENT (For EU Learners)
The AMA (American Medical Association) and UEMS (European Union of Medical Specialists) have an agreement of mutual recognition of Continuing Medical Education (CME) credits with the European Union of Medical Specialists (UEMS), the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 Credit™ to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMECs) should contact the UEMS at [email protected].
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
COMMISSION ON DIETETIC REGISTRATION
Med Learning Group designates this activity for a maximum of 1.0 CPEU.
SCOPE ACCREDITATION
This course is SCOPE Accredited for providing exceptional education standards, with content based on the latest evidence and free of commercial bias. It has been reviewed and independently validated by the World Obesity Federation’s Clinical Care Committee.
Earn 0.5 SCOPE points towards your SCOPE Certification – the only internationally recognized certification in obesity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs (eg,. physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
